Costs of Pharmacological and Non-Pharmacological Interventions in Interstitial Lung Disease Management in Germany.

Phillen Nozibuyiso Maqhuzu,Larissa Schwarzkopf,Philipp Markart,Juergen Behr,Rolf Holle,Reiner Leidl,Michael Kreuter

Respiration; international review of thoracic diseases（2022）

引用 0|浏览11

暂无评分

摘要

Stabilizing lung function and reducing the impact of PH and GERD are crucial in reducing the economic burden of ILD. There is an urgent need for effective treatment options, especially in CTD-ILD.

查看译文

关键词

Diffuse parenchymal lung disease,Direct costs,Healthcare expenditure,Healthcare spending,Interstitial lung disease management

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要